Glycos Biotechnologies

Glycos Biotechnologies is a small company based in Houston, Texas, specializing in research and development within the biotechnology field. With a team of 8 employees, Glycos Biotechnologies focuses on improving the delivery and performance of natural bioactive molecules. The company develops plant-based single-solution lipid absorption technologies to enhance the effectiveness of these molecules within the body. GlycosBio's solutions are designed to address diseases where the microbiome is impaired, collaborating with scientists and the medical community to create highly functional products. Their technologies leverage the inherent benefits of plant and marine lipids to provide safe and reliable personalized products. Glycos Biotechnologies is committed to nourishing and enhancing lives, particularly focusing on vulnerable populations experiencing microbiome dysbiosis. Their mission is to reduce reliance on antibiotics and prescription medications by utilizing plant-based alternatives. The company aims to modernize and elevate nutrition, skincare, and pulmonary health for all age groups through clean technology and clinically driven results. For more information about Glycos Biotechnologies and their innovative solutions, visit their website at glycosbio.com.